AS ONE Corporation (TYO:7476)
2,220.50
+7.50 (0.34%)
Jun 19, 2026, 3:30 PM JST
AS ONE Revenue
In the fiscal year ending March 31, 2026, AS ONE had annual revenue of 110.70B JPY with 6.70% growth. AS ONE had revenue of 31.49B in the quarter ending March 31, 2026, with 10.97% growth.
Revenue
110.70B
Revenue Growth
+6.70%
P/S Ratio
1.43
Revenue / Employee
151.43M
Employees
731
Market Cap
158.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 110.70B | 6.95B | 6.70% |
| Mar 31, 2025 | 103.75B | 8.22B | 8.60% |
| Mar 31, 2024 | 95.54B | 4.12B | 4.50% |
| Mar 31, 2023 | 91.42B | 4.47B | 5.14% |
| Mar 31, 2022 | 86.95B | 5.35B | 6.55% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.51T |
| Otsuka Holdings | 2.52T |
| Chugai Pharmaceutical | 1.29T |
| HOYA Corporation | 947.75B |
| H.U. Group Holdings | 247.36B |
| BML, Inc. | 150.26B |
| Kissei Pharmaceutical | 97.41B |
| Kaken Pharmaceutical | 76.87B |
AS ONE News
- 4 weeks ago - AS ONE Quarterly report: Q4 2026 - Filings
- 4 weeks ago - AS ONE Slides: Q4 2026 - Filings
- 5 months ago - AS ONE Quarterly report: Q3 2026 - Filings
- 7 months ago - AS ONE Quarterly report: Q2 2026 - Filings
- 7 months ago - AS ONE Slides: Q2 2026 - Filings
- 11 months ago - AS ONE Quarterly report: Q1 2026 - Filings
- 1 year ago - Hong Kong pro-democracy business hit with ‘unwarranted’ tax demand, owner says - Hong Kong Free Press